DA, Siqi. Effect of PD-1 Inhibitor on PI3K/AKT Pathway in Tumor Cell and TCell Activity in Non-small Cell lung Cancer (NSCLC). MedScien, [S. l.], v. 1, n. 1, p. 592, 2023. DOI: 10.61173/qhwyba55. Disponível em: https://ms.deanfrancis.press/article/view/1346. Acesso em: 4 nov. 2026.